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Abstract
Background: Pluripotent embryonal carcinomas are good potential models, to study, "in vitro," the
mechanisms that control differentiation during embryogenesis. The NTERA2cl.D1 (NT2/D1) cell
line is a well known system of ectodermal differentiation. Retinoic acid (RA) induces a dorsal
pattern of differentiation (essentially neurons) and bone morphogenetic protein (BMP) or
hexamethylenebisacetamide (HMBA) induces a more ventral (epidermal) pattern of differentiation.
However, whether these human cells could give rise to mesoderm derivatives as their counterpart
in mouse remained elusive. We analyzed the morphological characteristics and transcriptional
activation of genes pertinent in cardiac muscle and endothelium differentiation, during the growth
of NT2/D1 cells in an inductive angiomyogenic medium with or without Bone Morphogenetic
Protein 2 (BMP2).
Results: Our experiments showed that NT2/D1 maintains their typical actin organization in
angiomyogenic medium. Although the beta myosin heavy chain gene was never detected, all the
other 15 genes analyzed maintained their expression throughout the time course of the
experiment. Among them were early and late cardiac, endothelial, neuronal and teratocarcinoma
genes.
Conclusion: Our results suggest that despite the NT2/D1 cells natural tendency to differentiate
into neuroectodermal lineages, they can activate genes of mesodermal lineages. Therefore, we
believe that these pluripotent cells might still be a good model to study biological development of
mesodermal derivatives, provided the right culture conditions are met.
Background
Teratocarcinomas are highly malignant tumours, cells
that have a big potential to differentiate in other cell types.
They are considered to recapitulate many events occurring
in early embryogenesis, but with a lesser degree of organ-
ization and regulation, being also called embryonal carci-
nomas (EC) [1-5]. The "undifferentiated elements" of
these tumors are composed of EC cells or malignant
pluripotent stem cells that appear, in culture, as embryoid
body-like structures. After differentiation, they can also be
histologically positive for many somatic tissues such as
bone, muscle, nerve and others, these constituting the
"differentiated elements" of these tumors or the teratoma
components [6].
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any feeder layer to preserve its undifferentiated potential
and it may form embryoid body-like structures in vitro, a
feature also observed in other EC tumours [7-9]. The pres-
ence of some differentiating agents as RA, in the culture
medium, seems to activate the neuroectodermal differen-
tiating program [10], where the NT2/D1 cells give rise to
neural cells but also nonneural cells. However, even with-
out this agent, NT2/D1 can originate some neuronal-like
phenotypes [11].
When NT2/D1 cells give rise to neurons less than 10% of
the cells adopt this phenotype, while the rest of the cells
in the nonneural populations remain to be further ana-
lyzed and identified. Thus the hypothesis of mesodermal
derivatives from NT2/D1 cannot be excluded [10,12,13].
Nonneural cells were suggested to be primarily epithelial
in nature, by immunocytochemical staining, but the exact
identity of such cells has never been documented [11]. It
is suggested that this cell line although expressing meso-
dermal genes, does not adopt a mesodermal differentia-
tion program [13]. Most authors agree that this cell line
does not give rise to mesodermal derivatives; however,
opposite evidence has been recently documented, in a
BMP2 induced differentiation [14].
We believe that NT2/D1 might be the human counterpart
of P19, a mouse teratocarcinoma cell line with cardiac dif-
ferentiation potential. One of the genes highly expressed
in P19, that disappears after the differentiation is finished,
is Cripto [15]. This gene codes for a small cysteine-rich
protein that contains an epidermal growth factor (EGF)-
like motif and a CRIPTO/FRL1/Cryptic (CFC) motif.
CRIPTO is anchored in the cell membrane by a glycosyl-
phosphatidylinositol linkage where it functions as a core-
ceptor for Nodal, a member of the TGF-β family [16]. It
can be detected in the trophoblast and in the inner cell
mass of mouse blastocysts, becoming, thereafter restricted
to developing myocardium. Cripto knockout is lethal in
mouse and its inactivation in vivo results in the loss of
detection of some cardiac transcripts, such as, alpha myosin
heavy chain (α-MyHC), beta myosin heavy chain (β-MyHC),
atrial myosin light chain 2 (MLC-2a), ventricular myosin light
chain 2 (MLC-2v) and atrial natriuretic factor ANP [17]. In
embryonic stem cells (ESCs), its loss does not affect cell
commitment to the mesenchymal, endodermal or ecto-
dermal lineage, but results also in the absence of transcrip-
tion of cardiac specific genes. For all this, it has been
suggested, recently, that CRIPTO is a master gene regula-
tor in cardiomyogenesis. Expression of CRIPTO by NT2/
D1 cells has been shown by Baldassarre et al. [18].
To find a human embryonic cell line that could differenti-
ate with high frequency into myocardium and to identify
the factor(s) that would lead the cells through that path,
would be a powerful tool to study cardiomyogenesis, in
vitro.
Here, we have studied the cell morphology and the tran-
scription profile of the NT2/D1 cells cultured for 30 days
with and without BMP2. The gene expression analyzed
was particularly focused on EC, endothelial, neural pro-
genitors and early and late cardiac differentiation genes.




The typical NT2/D1 morphological characteristics, as the
increase in nuclear/cytoplasm volume ratio, the flattening
of the cells, the prominent nucleoli (Figure 1), the polym-
erized actin organization (phalloidin staining) and
ultrastructural analysis were used as the morphological
criteria to monitor cell differentiation.
As can be seen in figure 2, after 20 days in culture, in con-
trol as well as in IAM medium, NT2/D1 cells can form
many embryonic (white arrows) body-like structures, sur-
NT2/D1 cells in expansion mediumFigure 1
NT2/D1 cells in expansion medium. Phase contrast images of three typical morphologies of NT2/D1 cells in expansion 
medium, (RPMI, FBS and antibiotics) analyzed in a CK2 Olympus microscope: A. Embryoid body-like structures, magnification 
40×; B. epithelioid-like phenotype, magnification 100×; C. neuronal-like phenotype, magnification 200×.Page 2 of 9
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flattened cells, resembling a visceral endoderm phenotype
[19] with the interesting fact of presenting many vilosities.
When in an overconfluency state, many structures present
some similarities with an endothelial angiogenic network.
In contrast, neuronal-like cells could not be seen, indicat-
ing a possible inhibition of that phenotype with 20% FBS
or in IAM. Also, no muscular structures were ever detected
during the time course of the experiment.
Ultrastructural analysis
As mentioned above, some villosities could be detected in
TEM (figure 2, TEM, control). This finding is consistent
with the tendency that the NT2/D1 cells have to differen-
tiate through an epithelial path. Desmosomes are visible
between adjacent cells (figure 2, black arrow), which
would be consistent with a muscular phenotype, however,
specific morphologies of the latter tissue, like sarcomeres,
were not ever found, [see Additional file 1].
Transcriptional analysis
To see if would be any tendency of NT2/D1 to differenti-
ate in a more muscle related or endothelial related fash-
ion, genes specific for that tissues were chosen, ([see
Additional file 2] and Figure 3):
Muscle related genes
At all time points analyzed, NT2/D1 cells expressed undif-
ferentiated cardiac specific genes, like GATA4, CSX1 and
MEF2D, as well as differentiated cardiac specific genes as
VLC1 and VLC2. The slow muscle myosin heavy chain gene
(MYH7), found in cardiac but also in some skeletal mus-
cles, was the sole gene, of those analyzed that was not
detect in this study. Although the primers for the MYH7
were specific for this gene, the bands that were found were
nonspecific products of the polymerase reaction, giving
rise to a specific pattern of expression in the particular cell
line tested. Curiously, non muscular tissues also gave rise
to nonspecific products with the specific MYH7 primers,
[see Additional file 3].
Endothelial progenitor related genes
Transcripts of CD133 and the VEGF receptor 2, KDR, could
be detected at all time points of the experiment. This find-
ing could reflect the angiogenic potential of these cells
[20,21]. In fact, there are some images in the differentia-
tion cultures that remind angiogenic like networks, but
further studies are obviously needed to prove this concept.
Other progenitor related genes
Knowing that NT2/D1 expresses the CD133 and that these
cells easily undergo neural differentiation, we would
expect to detect expression of NESTIN [22,23]. That was
indeed the case. NESTIN expression was detected from the
first day of the experiment. On the other hand, the expres-
sion of FLT1 indicated that these cells could be considered
not only endothelial but also haematopoietic progenitor
cells as described by others [24,25].
Bone morphogenetic protein receptors (BMPRs)
Because one of our main hypothesis was that BMP2 was
an inducer of mesodermal differentiation in NT2/D1 cul-
tures, we analyzed whether the main BMP receptor genes,
namely BMPRIA, BMPRIB and BMPRII [26,27] were tran-
scriptionally active. Type II receptors can bind ligands in
the absence of type I receptors, but they need their respec-
tive type I receptors to transduce the signal [28,29].
BMPRIA, BMPRIB and BMPRII transcripts could be
detected in the 5 time points of the experiment. Interest-
ingly, the heavy isoform of BMPRIB was only detected
after 30 days in the angiomyogenic medium. The mecha-
nism underlying this phenomenon remains to bee clari-
fied.
NT2/D1 related genes
H19 is a gene that is expressed in a vast number of organs
during fetal development. In adults, however, expression
is confined to lung, thymus, skeletal and cardiac muscle
[30]. Accordingly, in EC cells it is expressed after induc-
tion of differentiation [15,30-33]. Our experiments
showed that NT2/D1 expressed H19 throughout the time
course of the experiment, [see Additional file 4].
As mentioned before, one of the genes highly expressed in
P19 cells, a murine EC, with cardiac differentiation poten-
tial is Cripto, that disappears after the differentiation is fin-
ished [15]. As expected, we detect in the NT2/D1 cell line
relative good levels of CRIPTO expression that changed to
a more unspecific pattern in the last days of the experi-
ment, suggesting that NT2/D1 had differentiated [18].
The expected band for CRIPTO was 1199 bp. So, the sig-
nificance of the several unexpected bands that have
appeared in NT2/D1 after some days in culture remains to
be clarified, [see Additional file 4]. This similarity between
P19 and NT2/D1 cells supported our initial hypothesis,
that in the appropriate conditions, NT2/D1 cells could
give rise to mesodermal derivatives, such as skeletal or car-
diac muscle.
Discussion
Despite the difference of human and mouse EC at the
level of cell surface markers, they share some common
characteristics, such as, the morphology of little cyto-
plasm, prominent nucleoli and the preferential clustering
growth pattern. In this line of thought, one can say that
the mouse teratocarcinoma cell line, P19, has a relevant
similar behavior to NT2/D1, also, regarding the potential
of both to originate neuroectodermal derivatives in the
presence of retinoic acid.Page 3 of 9
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NT2/D1 cells in IAM mediumFigure 2
NT2/D1 cells in IAM medium. Cell culture images of NT2/D1 cells after 20 days growing in control, IAM and IAM+BMP2 
medium. All the non fluorescent and fluorescent images are 100× magnified and analyzed in a CK2 and BX50 Olympus micro-
scope, respectively. Ultrastructural images have a scale bar in the bottom right corner. NT2/D1 cells formed many embryonic 
body-like structures (white arrows), surrounded by an epithelioid squamous layer of adherent flattened cells. Desmosomes can 
be seen between adjacent cells (TEM black arrow). To see non fluorescent and fluorescent images of days 1, 5, 10 and 30, 
please [see Additional file 4].
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to mesodermal derivatives, such as, smooth muscle, skel-
etal muscle and cardiac muscle [34,35]. The last two proc-
esses, can be also induced by dimethylsulphoxide
(DMSO) [36] and the cardiac differentiation inhibited by
noggin [37], a BMP2 antagonist, indicates that probably,
this growth factor is essential in this inductive process.
BMP2, belonging to the transforming growth factor super-
family, is involved in many important processes in early
human and mouse development [19,38-43] and have a
variety of effects in human and mouse teratocarcinomas.
It can induce epithelial differentiation in NT2/D1 [44]
and endodermal differentiation in GCT27X-1 EC and
human ESCs [19,45], however in P19 cells it can give rise
also to mesodermal derivatives like cardiac muscle [37].
Contrarily to human ESCs, treatment of mouse ESCs with
BMP2 and/or FGF2 efficiently enhanced cardiomyogene-
sis [46].
For this, BMP2 has been considered to be an inhibitor of
the neural differentiation program and an embryonic
ectoderm [11] or extra-embryonic endoderm epidermal
inducer in human pluripotent stem cells [19], but also a
mesodermal inducer in the mouse pluripotent stem cells
[47]. Only recently, has the latter role been documented
[14], in humans.
We also believe that BMP2 can indirectly induce NT2/D1
cells into mesodermal derivatives like cardiac muscle,
because: 1) observations from amphibians, chicks and
more recently from mice, have proposed that the factors
produced by embryonic endoderm are good candidates to
be cardiogenic inducers [48]; 2) BMPs, as BMP2, have a
role in visceral endoderm differentiation in the mouse
[49] and in the human ESCs system [50]; 3) the mouse
P19CL6noggin EC cell line that overexpresses the BMP2
antagonist noggin and has lost it potential to differentiate
into cardiomyocytes, can regain that property when in the
presence of excess BMP2 protein [37]; 4) recently, it has
been shown that the mouse visceral endoderm-like cell
line END2, derived from P19 EC, when cocultured with
the parental cells [51] or mouse ESCs [52] induces spon-
taneous aggregation and differentiation into cardiac mus-
cle, in the absence of BMP2. The same effect could be
obtained with END2 conditioned medium [52]. Curi-
ously, in humans one can also obtain cardiomyocytes by
coculturing human ESCs with mouse END2 [52,53]. The
latter findings indicate that the visceral endoderm-like
cells and not the BMP2, are the primary key for myocar-
dial differentiation. Apparently, END2 cells produce one
or more factors that promote cardiac differentiation.
Hence, one can say that the main potential of P19 cells to
spontaneously differentiate into cardiac derivatives may
come from the factors produced by the cells that under-
gone the visceral endoderm-like differentiation, thus,
inducing other cells to the mesodermal lineage. So, we
speculate that when the BMP2 is present it may contribute
indirectly to cardiomyogenesis by increasing the number
of visceral endoderm like cells in culture.
Then, if BMP2 can inhibit the neural fate and induce the
mesodermal and the visceral endoderm-like phenotype in
NT2/D1 cells it would possibly induce some cells to the
cardiac lineage too. Unfortunately, morphological signals
of muscle differentiation as myotube formation and sar-
comeric intracellular actin organization were not
detected, in an angiomyogenic inductive medium, in the
presence of BMP2 or in 5-Aza treated cells, as we did not
see any muscle beating areas at all the time points of the
experiment, indicating that the NT2/D1 were not commit-
ted to mesodermal lineages like striated muscle, but
instead, they differentiate mainly into the expected epi-
thelioid morphologies. There were some cultures that
exhibit some angiomyogenic like structures, but further
studies are needed to confirm that.
Expression studiesFigure 3
Expression studies. Polaroid images of 0,8% agarose gels 
with Ethidium Bromide of polymerase amplified gene prod-
ucts of NT2/D1 cells cDNA. In the first and last lanes one 
can see the 1 Kb ladder (Invitrogen). To see gel images of the 
days 1, 5, 10 and 30, or other details related to the amplified 
products and primers, please [see Additional file 4].Page 5 of 9
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VLC2, MEF2D, GATA4 and CSX1) and endothelial (KDR
and CD133) mesodermal lineages, bone morphogenetic
protein receptors (BMPRIA, BMPRIB and BMPRII) and
NT2/D1 specific were detected in a qualitative and consti-
tutive manner during the time course of the experiment.
CRIPTO, a suggested master gene regulator in cardiogen-
esis, is one of the genes highly expressed in cardiomyo-
genic P19 cells. Accordingly, we detect in the NT2/D1 cell
line good levels of CRIPTO expression, strengthening our
initial hypothesis, that in appropriate conditions, NT2/
D1 cells can possibly give rise to mesodermal derivatives,
such as cardiac muscle. During the time course of the
experiment, CRIPTO transcripts tended to become more
difficult to visualize while H19 transcripts more easy to
detect, a signal that NT2/D1 were differentiating, at least
regarding this genes, in a similar manner as their mouse
counterpart P19.
Conclusion
We believe that the apparent blockage of the differentia-
tion pathways in vitro through a mesodermal commit-
ment may reside on unknown pos-transcriptional or pos-
translational mechanisms.
Another possibility is that the aneuploid state of NT2/D1
cells inhibits the key differentiating genes, and that what
was once an advantage, regarding the tumor clonal selec-
tion of differentiation-resistant cells, is now a relevant
obstacle in differentiation studies like this one.
Still, identifying the factors capable of regulating differen-
tiation of pluripotent human EC cell lines, will give us
clues for as to how manipulate human stem cells, an




NT2/D1 cells (Stratagene) were cultured and expanded in
80 cm2 flasks in RPMI 1640 medium without Glutamine
(Invitrogen), with 10 mM HEPES (Invitrogen), 20 μM 2-
β-Mercaptoetanol (Sigma), 2 mM Glutamine (Invitrogen)
10% FBS (Invitrogen) and 1% (v/v) Penicillin 10000 IU/
ml + Streptomycin 10 mg/ml (Invitrogen) and left for
growth to 80% confluence, harvested by scraping and
reseeded 1:4, continuously until they were needed.
In angiomyogenic induction, NT2/D1 cells were sus-
pended in inductive angiomyogenic medium (IAM) with
endothelial cell growth supplement (ECGS) as described
by Shmelkov et al [54]: Briefly, cells were cultured in
M199 Medium (Invitrogen) supplemented with 20% FBS
(Invitrogen), 10 mM HEPES (Invitrogen), 1 U Heparin
(Sigma), 1% (v/v) Penicillin 10000 IU/ml + Streptomycin
10 mg/ml (Invitrogen), 10 ng/ml VEGF (Sigma), 5 ng/ml
bFGF (Sigma), 50 ng/ml BDNF (Invitrogen) and 150 μg/
ml ECGS and seeded at 1000 cells/cm2 on glass or ther-
manox coverslips coated with 2% gelatin, in 24-well
dishes. The seeded cells were left for the first 24 h in 10 μM
5-Azacytidine and then washed and resuspended in the
same initial medium. BMP2, at the concentration of 100
ng/ml, was added to IAM (IAM+BMP2). Medium without
VEGF, bFGF, BDNF and ECGS was used as control (Con-
trol). Cells were harvested on day 1, 5, 10, 20 and 30 after
initiation of culture and used for histological, ultrastruc-
tural and RT-PCR analysis.
Reverse Transcription Polymerase Chain Reaction (RT-
PCR) Analysis
Total RNA was extracted according to Trizol total RNA
extraction protocol (Invitrogen). cDNA first strand syn-
thesis was performed on 1 μg total RNA, by using the
ThermoScript RT-PCR System (Invitrogen) with an oligo
dT primer. As a second step, cDNA samples were subjected
to PCR amplification, in a separate tube, using primers
specific for the gene of interest, [see Additional files 5 and
6], with the Platinum Taq DNA Polymerase High Fidelity
(Invitrogen) using 40 cycles at 56°C. For each gene, the
DNA primers were derived from different exons, allowing
the distinction between cDNA and contaminating
genomic DNA amplifications. Primers were synthesized
for the following human genes: ACTB, VLC1, VLC2,
MYH7, CSX1, GATA4, MEF2D, BMPRIA, CRIPTO, H19,
Nestin, FLT1, CD133, KDR, BMPRIB, and BMPRII.
Histochemistry
Glass coverslips, containing the NT2/D1 cells, were fixed
for 30 min with the addition of buffered formaldehyde
pH 7.0 into the cell culture wells at a 2% final concentra-
tion, washed in D-PBS pH 7,2–7,4 (Invitrogen) and
stored at 4°C until processed. When processed, coverslips
were washed in water, immersed in Harris's hematoxylin
(Merck) for 10 minutes, washed in water, differentiated in
70% EtOH with 1% HCl for 10 seconds, immersed in
eosin Y (Merck) for 10 seconds and washed again. Stained
cells in coverslips were dehydrated in graded series of eth-
anol, followed by xylol (Merck), and mounted on glass
microscope slides, cell side down, using entellan (Merck).
Phalloidin staining
Dilution of phalloidin-TRITC stock solution (Sigma) and
washing of the glass coverslips were performed in D-PBS
pH 7,2–7,4 containing 0,05% saponin (Sigma). Cover-
slips were fixed for 30 min with the addition of buffered
formaldehyde pH 7.0 into the cell culture wells at a 2%
final concentration, incubated with 1 μg/ml phalloidin-
TRITC solution for 90 min at RT and washed 3 times. The
coverslips were then mounted on microscope slides, cellPage 6 of 9
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Olympus BX50 microscope.
Ultrastructural analysis
Thermanox coverslips (Nunc) from day 20, were fixed in
0,1 M sodium cacodylate buffer (EMS) pH 7,3 with 3%
gluteraldeyde (EMS) for 1 h, washed in 0,1 M sodium
cacodylate, followed by 1% osmium tetroxide (EMS) in
the same buffer for 1 h and washed again, first in
cacodylate buffer and then in 0,1 M sodium acetate buffer
(Merck) pH 5,0. Fixed cells were incubated with 1% ura-
nyl acetate (EMS) in 0,1 M sodium acetate buffer pH 5,0
for 1 h, washed in the same buffer, dehydrated in graded
series of ethanol, followed by propylene oxide (EMS),
embedded in epon (EMS) and left for 3 days at 70°C. Thin
sections cut on a LKB III microtome with a diamond knife
for transmission electron microscopy (TEM) were stained
on 300 mesh square copper grids with 2% uranyl acetate
and lead citrate (Fluka) and observed in a Philips CN10
transmission electron microscope. All the steps were
made at room temperature, except when otherwise docu-
mented.
Sequencing
The PCR products were purified using Qiaquick PCR puri-
fication kit (Quiagen) as described by the manufacturer
and visualized by ethidium bromide after electrophoresis
in a 1% agarose gel. A molecular weight standard a 1 kb
DNA ladder (Invitrogen,) was used. All sequences were
determined in an automated DNA capillary sequencer
CEQ 2000-XL (Beckman Coulter, USA, in ICAT – Lisbon
Faculty of Sciences Sequencing Services) by a dye-labeled
dideoxy termination method (DTCS, Dye Terminator
Cycle sequencer start kit, Beckman Coulter). Two
sequencing reactions were performed using the two prim-
ers used for PCR amplification. The sequences obtained,
were compared with existing gene data from the National
Centre for Biotechnology Information (GenBank) for all
the amplified genes. All the primers have given rise to the
expected amplified fragments.
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Human pluripotent embryonal carcinoma NT2/D1 in an angiomyogenic 
medium. TEM images at differentiation day 20.




Human pluripotent embryonal carcinoma NT2/D1 in an angiomyo-
genic medium. RT-PCR Qualitative analysis. This is not a quantitative 
analysis, what is the best choice to compare transcripts of different genes. 
However, a qualitative analysis can be done, comparing the intensity of 
the gel bands with the intensity of a house keeping gene, in our case the β 
actin. The scores we have chosen to construct these graphics were: 0 – PCR 
product not detected; 1 – PCR product with much less intensity of the β 
actin product; 2 – PCR product with less intensity of the β actin product; 
3 – PCR product with the intensity of the β actin product; 4 – PCR prod-
uct with more intensity of the β actin product; 5 – PCR product with much 
more intensity of the β actin product. Of course, that with this method the 
conclusions one can take are very limited, and only big differences have 
caught our attention. The main observations were: i) contrarily to what 
we have expected, in general, all genes were equally expressed in the dif-
ferent time points analyzed, with the exception of the MYH7 that was 
never detected; ii) the gel band of CRIPTO has tendency to change to a 
specific pattern during NT2/D1 differentiation; iii) a DNA band of 
BMPRIB appears in late stages of NT2/D1 differentiation. We cannot 
exclude DNA contamination in the PCR reaction, but if so, and because 
all the other reactions used the same cDNA, why was this gene the only 
one presenting a DNA amplified band? We do not have a explanation for 
this. iv) the heavy band of BMPRII appears only in late stages of NT2/D1 
differentiation.




Human pluripotent embryonal carcinoma NT2/D1 in an angiomyo-
genic medium. The case of the MYH7 PCR. The MYH7 primers were 
constructed and positively verified for accuracy using cDNA samples of 
human masseter and human left ventricle, which are muscle tissues 
known to express this gene in a high relative level. With that samples we 
could obtain single band PCRs positively verified by sequencing. (see the 
two last lanes before the ladder in the gel image). The first time we have 
used the MHY7 primers in non muscle tissues, we have obtained a pattern 
of expression that was very interesting at the beginning, because we 
thought that we were leading with an alternative splicing event. However, 
after sequencing, the PCR products of different sizes that the NT2/D1 and 
other samples gave rise in the polymerase reaction with the MYH7 prim-
ers, had nothing to do with the expected results, as one can see in the fig-
ure. The five non specific bands in the NT2/D1 lane are marked from 1 
to 5 with the respective sequentiation results shown below.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1477-
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